#clinical-trials
Women's Clinical Trials & CROs Market Forecast to More Than Double by 2036 as Precision Medicine Reshapes Trial Design
A new 456-page report projects the global women's clinical trials and CRO market will grow from $9.9 billion in 2026 to $22.3 billion by 2036, as biomarker-driven research and decentralized trial models transform how women's health studies are designed and ru…
India could be on the radar for AstraZeneca’s oral GLP-1 drug: MD
AstraZeneca’s MD hints at India’s potential inclusion in global trials for its promising oral GLP-1 weight loss and diabetes drug.
Avance Clinical Announces Asia Pacific and Mainland China Expansion Ahead of BIO International Convention 2026
Avance Clinical Announces Asia Pacific and Mainland China Expansion Ahead of BIO International Convention 2026...
Avance Clinical Announces Asia Pacific and Mainland China Expansion Ahead of BIO International Convention 2026
Avance Clinical Announces Asia Pacific and Mainland China Expansion Ahead of BIO International Convention 2026 ...
Ophthalmic Clinical Trials Market Size to Reach USD 3.30 Billion by 2035 as Gene Therapy and Retinal Disease Drug Development Accelerate – SNS Insider
The U.S. Ophthalmic Clinical Trials Market was valued at USD 0.66 Billion in 2025 and is projected to reach USD 1.25 Billion by 2035, while Europe is expected to grow from USD 0.49 Billion to USD 0.89 Billion during the forecast period, driven by expanding re…
Wockhardt gets CDSCO nod for Zaynich antibiotic
Wockhardt Ltd has secured approval from the CDSCO for its new antibiotic, Zaynich. This drug is developed in India and will be used to treat complicated urinary tract infections in adults. The approval follows successful clinical trials. Zaynich shows potenti…
Asia Drug Development Beyond China Strategic Intelligence Report 2026: Pharma R&D and Deal Trends in South Korea, Japan, and India
Asia's drug development market opportunities include China's leadership, the dominance of small molecules and oncology, and increased clinical trial activity in South Korea and India. Japan focuses on multinational trials, with licensing preferred over M&A. O…
BREAKINGNew Ebola Vaccine Reportedly Nearing Clinical Trials (Live Updates)
The vaccine, which hasn’t been tested on humans, would be the first capable of treating the deadly Bundibugyo strain of Ebola.
ICMR moves to cut clinical trial delays with single ethics review system
India News: NEW DELHI: In a move aimed at speeding up medical research and reducing delays in clinical trials, the Indian Council of Medical Research (ICMR) has i.
Sourav K. Mishra, M.D. / All India Institute of Medical Sciences - 724881 - 04/29/2026
In Vivo Bioavailability-Bioequivalence Studies – Clinical
Electronic Clinical Outcome Assessment (eCOA) Solutions Global Market Forecast Report 2026: Market to Reach $7.46 Billion by 2036 - Opportunities in Digital Health Expansion and Personalized Analytics
The global Electronic Clinical Outcome Assessment (eCOA) Solutions Market, driven by trends toward decentralized, patient-centric clinical trials, is projected to grow from USD 1.94 billion in 2026 to approximately USD 7.46 billion by 2036, at a CAGR of 14.4%…
Fibromyalgia Market Competitive Landscape Report 2026: Market is Not Likely to See Any Major Shifts in the Near Term, with No Products in Pre-registration or Phase III Development.
The main market opportunities in fibromyalgia therapeutics include the significant number of anticipated cases in India by 2029, a limited treatment landscape with few approved drugs and generics dominance, and untapped potential in early-stage clinical asset…
clinicaltrials-mcp added to PyPI
Conversational access to ClinicalTrials.gov — an MCP server for pharma analysts, CRO teams, and health-tech builders
Clinical Trials Market Insights and Growth Outlook to 2033 - Shift Towards Patient-Centric and Technology-Driven Trial Models Transforming the Industry
Asia-Pacific offers cost-effective growth. Precision medicine, chronic disease prevalence, and strategic partnerships further drive expansion in this evolving sector. Asia-Pacific offers cost-effective growth. Precision medicine, chronic disease prevalence, a…
Drug Trials Snapshots: QFITLIA
QFITLIA is an antithrombin-directed small interfering ribonucleic acid indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients aged 12 years and older with hemophilia A or B with or without fac…
Clinical Trials Market Analysis/Forecasts 2026-2034 by Phases, Indications, Study Designs, Countries and Competitive Landscape
The clinical trials market is forecasted to experience strong growth, expanding from $92.63 billion to $158.1 billion between 2025 and 2034, driven by rising pharmaceutical and biotechnology R&D, chronic disease prevalence, and demand for innovative treatment…